Industry influence in evidence production.
Industry influence in evidence production.
复制标题
证据制作方面的行业影响力。
DOI：
10.1136/jech-2013-202344
复制
发表时间：
2013
影响因子：
6.3
通讯作者：
Coiera,Enrico
中科院分区：
文献类型：
--
作者：
Dunn,AdamG;Bourgeois,FlorenceT;Coiera,Enrico
鉴于最近的一些药物开发和营销争议，公众越来越关注行业在决定如何使用药物方面的作用。1-3评估资金如何影响临床试验证据的设计、报告和合成的新方法已经确定了行业参与证据生产的广度。对公众健康的下游影响仍然难以量化。为了识别和减轻任何一种类型的试验申办者的潜在影响，我们认为，这些新方法现在应该被常规和系统地使用，在一个过程中，我们称之为证据监督。
In light of a number of recent drug development and marketing controversies, there is increasing public focus on the role of industry in determining how drugs are used. 1–3 New methods that evaluate how funding has influenced the design, reporting, and synthesis of evidence from clinical trials have identified the breadth of industry involvement in evidence production. The downstream effects on public health remain difficult to quantify. In order to identify and mitigate the potential effects of any one type of trial sponsor, we argue that these new methods should now be used routinely and systematically, in a process we call evidence surveillance.